Rank ligand as a target in musculoskeletal neoplasms

le Cote, Gregory M.
Foilsithe in Curr Rev Musculoskelet Med (2015)

Next‐Generation Sequencing for Patients with Sarcoma: A Single Center Experience

le Cote, Gregory M., He, Jie, Choy, Edwin
Foilsithe in Oncologist (2017)

Targeting programmed cell death ligand 1 in osteosarcoma: an auto-commentary on therapeutic potential

le Shen, Jacson K, Cote, Gregory M, Choy, Edwin, Hornicek, Francis J, Duan, Zhenfeng
Foilsithe in Oncoimmunology (2014)

Inhibition of ATR-Chk1 signaling blocks DNA double-strand-break repair and induces cytoplasmic vacuolization in metastatic osteosarcoma

le Li, Xiaoyang, Dean, Dylan C., Cote, Gregory M., Zou, Lee, Hornicek, Francis J., Yu, Shengji, Duan, Zhenfeng
Foilsithe in Ther Adv Med Oncol (2020)

Targeting EZH2-mediated methylation of H3K27 inhibits proliferation and migration of Synovial Sarcoma in vitro

le Shen, Jacson K., Cote, Gregory M., Gao, Yan, Choy, Edwin, Mankin, Henry J., Hornicek, Francis J., Duan, Zhenfeng
Foilsithe in Sci Rep (2016)

Spindle and round cell sarcoma with EWSR1-PATZ1 gene fusion: A sarcoma with polyphenotypic differentiation

le Chougule, Abhijit, Taylor, Martin, Nardi, Valentina, Chebib, Ivan, Cote, Gregory M, Choy, Edwin, Nielsen, G. Petur, Deshpande, Vikram
Foilsithe in Am J Surg Pathol (2019)

Palmitate alters neuregulin signaling and biology in cardiac myocytes

le Miller, Thomas A, Icli, Basak, Cote, Gregory M, LeBrasseur, Nathan K, Borkan, Steve C, Pimentel, David R., Peng, Xuyang, Sawyer, Douglas B
Foilsithe 2008

Myxoid Liposarcoma: Treatment Outcomes from Chemotherapy and Radiation Therapy

le Chowdhry, Varun, Goldberg, Saveli, DeLaney, Thomas F., Cote, Gregory M., Chebib, Ivan, Kim, Jason, Lozano-Calderón, Santiago A., De Amorim Bernstein, Karen
Foilsithe in Sarcoma (2018)

CD44 is a direct target of miR-199a-3p and contributes to aggressive progression in osteosarcoma

le Gao, Yan, Feng, Yong, Shen, Jacson K., Lin, Min, Choy, Edwin, Cote, Gregory M., Harmon, David C., Mankin, Henry J., Hornicek, Francis J., Duan, Zhenfeng
Foilsithe in Sci Rep (2015)

Genotyping Cancer-Associated Genes in Chordoma Identifies Mutations in Oncogenes and Areas of Chromosomal Loss Involving CDKN2A, PTEN, and SMARCB1

le Choy, Edwin, MacConaill, Laura E., Cote, Gregory M., Le, Long P., Shen, Jacson K., Nielsen, Gunnlaugur P., Iafrate, Anthony J., Garraway, Levi A., Hornicek, Francis J., Duan, Zhenfeng
Foilsithe 2014

Prognostic Factors in Dedifferentiated Chondrosarcoma: A Retrospective Analysis of a Large Series Treated at a Single Institution

le Miao, Ruoyu, Choy, Edwin, Raskin, Kevin A., Schwab, Joseph H., Nielsen, Gunnlaugur Petur, Deshpande, Vikram, Chebib, Ivan, DeLaney, Thomas F., Hornicek, Francis J., Cote, Gregory M., Chen, Yen-Lin E.
Foilsithe in Sarcoma (2019)

Programmed cell death 1 ligand 1 expression in osteosarcoma

le Shen, Jacson K., Cote, Gregory M., Choy, Edwin, Yang, Pei, Harmon, David, Schwab, Joseph, Nielsen, G. Petur, Chebib, Ivan, Ferrone, Soldano, Wang, Xinhui, Wang, Yangyang, Mankin, Henry, Hornicek, Francis J., Duan, Zhenfeng
Foilsithe 2014

Phase I Study of Oral Abexinostat, a Histone Deacetylase Inhibitor, in Combination with Doxorubicin in Patients with Metastatic Sarcoma

le Choy, Edwin, Flamand, Yael, Balasubramanian, Sriram, Butrynski, James E., Harmon, David C., George, Suzanne, Cote, Gregory M., Wagner, Andrew J., Morgan, Jeffrey A., Sirisawad, Mint, Mani, Chitra, Hornicek, Francis J., Duan, Zhenfeng, Demetri, George D.
Foilsithe in Cancer (2014)

Phase II study of olaparib in patients with refractory Ewing sarcoma following failure of standard chemotherapy

le Choy, Edwin, Butrynski, James E, Harmon, David C, Morgan, Jeffrey A, George, Suzanne, Wagner, Andrew J, D’Adamo, David, Cote, Gregory M, Flamand, Yael, Benes, Cyril H, Haber, Daniel A, Baselga, Jose M, Demetri, George D
Foilsithe in BMC Cancer (2014)

A First‐in‐Human Phase I Study of OPB‐111077, a Small‐Molecule STAT3 and Oxidative Phosphorylation Inhibitor, in Patients with Advanced Cancers

le Tolcher, Anthony, Flaherty, Keith, Shapiro, Geoffrey I., Berlin, Jordan, Witzig, Thomas, Habermann, Thomas, Bullock, Andrea, Rock, Edwin, Elekes, Agnes, Lin, Chester, Kostic, Dusan, Ohi, Naoto, Rasco, Drew, Papadopoulos, Kyriakos P., Patnaik, Amita, Smith, Lon, Cote, Gregory M.
Foilsithe in Oncologist (2018)

Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Safety and Clinical Activity in Patients With Advanced Chondrosarcoma

le Tap, William D., Villalobos, Victor M., Cote, Gregory M., Burris, Howard, Janku, Filip, Mir, Olivier, Beeram, Murali, Wagner, Andrew J., Jiang, Liewen, Wu, Bin, Choe, Sung, Yen, Katharine, Gliser, Camelia, Fan, Bin, Agresta, Sam, Pandya, Shuchi S., Trent, Jonathan C.
Foilsithe in J Clin Oncol (2020)

MicroRNA-mRNA networks define translatable molecular outcome phenotypes in osteosarcoma

le Lietz, Christopher E., Garbutt, Cassandra, Barry, William T., Deshpande, Vikram, Chen, Yen-Lin, Lozano-Calderon, Santiago A., Wang, Yaoyu, Lawney, Brian, Ebb, David, Cote, Gregory M., Duan, Zhenfeng, Hornicek, Francis J., Choy, Edwin, Petur Nielsen, G., Haibe-Kains, Benjamin, Quackenbush, John, Spentzos, Dimitrios
Foilsithe in Sci Rep (2020)

Targeting Sporadic and Neurofibromatosis Type 1 (NF1) Related Refractory Malignant Peripheral Nerve Sheath Tumors (MPNST) in a Phase II Study of Everolimus in Combination with Beva...

le Widemann, Brigitte C., Lu, Yao, Reinke, Denise, Okuno, Scott H., Meyer, Christian F., Cote, Gregory M., Chugh, Rashmi, Milhem, Mohammed M., Hirbe, Angela C., Kim, AeRang, Turpin, Brian, Pressey, Joseph G., Dombi, Eva, Jayaprakash, Nalini, Helman, Lee J., Onwudiwe, Ndidi, Cichowski, Karen, Perentesis, John P.
Foilsithe in Sarcoma (2019)

Development and Preliminary Clinical Activity of PD-1-Guided CTLA-4 Blocking Bispecific DART Molecule

le Berezhnoy, Alexey, Sumrow, Bradley J., Stahl, Kurt, Shah, Kalpana, Liu, Daorong, Li, Jonathan, Hao, Su-Shin, De Costa, Anushka, Kaul, Sanjeev, Bendell, Johanna, Cote, Gregory M., Luke, Jason J., Sanborn, Rachel E., Sharma, Manish R., Chen, Francine, Li, Hua, Diedrich, Gundo, Bonvini, Ezio, Moore, Paul A.
Foilsithe in Cell Rep Med (2020)

ACTR-46. AG-120, A FIRST-IN-class MUTANT IDH1 INHIBITOR IN PATIENTS WITH RECURRENT OR PROGRESSIVE IDH1 MUTANT GLIOMA: UPDATED RESULTS FROM THE PHASE 1 NON-ENHANCING GLIOMA POPULATI...

le Mellinghoff, Ingo K, Touat, Mehdi, Maher, Elizabeth, De La Fuente, Macarena, Cloughesy, Timothy F, Holdhoff, Matthias, Cote, Gregory M, Burris, Howard, Janku, Filip, Huang, Ray, Young, Robert J, Ellingson, Benjamin, Nimkar, Tara, Jiang, Liewen, Ishii, Yuko, Choe, Sung, Fan, Bin, Steelman, Lori, Yen, Katharine, Bowden, Chris, Pandya, Susan, Wen, Patrick Y
Foilsithe in Neuro Oncol (2017)